New analysis from the IMPACT-TD Registry demonstrates that treatment with AUSTEDO and AUSTEDO XR led to reductions in ...

Teva Pharmaceutical Industries Limited ( TEVA) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 8:00 AM EDT ...

Teva's transformation is gaining momentum.

We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’ Substack by Kontra. In this article, we will summarize the bull’s thesis on TEVA. Teva Pharmaceutical ...

Teva Pharmaceutical Industries Limited TEVA announced that the European Medicines Agency (“EMA”) has accepted its marketing ...

Israel-headquartered Teva Pharmaceutical Industries has announced the launch of Ahzantive (aflibercept), a biosimilar to ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited (NYSE:TEVA) ...

Good morning, everyone. My name is Balaji Prasad. I'm the Senior Analyst for the Specialty Pharmaceuticals sector for Barclays. It is my privilege to kick off our Spec Pharma track with Teva ...

Baron Funds, an investment management company, released its fourth-quarter investor letter for the “Baron Health Care Fund”. A copy of the letter can be downloaded here. The fund rose 13.10% ...

New analysis from the IMPACT-TD Registry demonstrates that treatment with AUSTEDO and AUSTEDO XR led to reductions in Abnormal Involuntary Movement Scale (AIMS) scores in all participants, which were ...